Etomidate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for etomidate and what is the scope of patent protection?
Etomidate
is the generic ingredient in two branded drugs marketed by Hospira, Avet Lifesciences, Caplin, Endo Operations, Eugia Pharma, Gland Pharma Ltd, Hikma, Luitpold, Mylan Labs Ltd, Rising, and Zydus Pharms, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.There are six drug master file entries for etomidate. Fourteen suppliers are listed for this compound.
Summary for etomidate
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 11 |
NDAs: | 12 |
Drug Master File Entries: | 6 |
Finished Product Suppliers / Packagers: | 14 |
Raw Ingredient (Bulk) Api Vendors: | 83 |
Clinical Trials: | 100 |
Patent Applications: | 6,604 |
Drug Prices: | Drug price trends for etomidate |
What excipients (inactive ingredients) are in etomidate? | etomidate excipients list |
DailyMed Link: | etomidate at DailyMed |
Recent Clinical Trials for etomidate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ahon Pharmaceutical Co., Ltd. | Phase 1 |
Hartford Hospital | Phase 4 |
Jason Chui | Phase 4 |
Pharmacology for etomidate
Drug Class | General Anesthetic |
Physiological Effect | General Anesthesia |
Medical Subject Heading (MeSH) Categories for etomidate
Anatomical Therapeutic Chemical (ATC) Classes for etomidate
US Patents and Regulatory Information for etomidate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Endo Operations | ETOMIDATE | etomidate | INJECTABLE;INJECTION | 091297-001 | Jun 20, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Mylan Labs Ltd | ETOMIDATE | etomidate | INJECTABLE;INJECTION | 201044-001 | Feb 7, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hikma | ETOMIDATE | etomidate | INJECTABLE;INJECTION | 074593-001 | Nov 4, 1996 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hikma | ETOMIDATE | etomidate | INJECTABLE;INJECTION | 202354-001 | Feb 25, 2016 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.